Saturday 7 November 2026
Export NUVB’s income statement to Excel — free account
Nuvation Bio Inc.
NUVB Healthcare Biotechnology
Nuvation Bio Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.9 million, up 699.0% from fiscal 2024.
- Revenue
- +242.6%
- EPS
- +25.6%
- Free cash flow
- +34.1%
- Total debt
- +441.5%
Quarter to September 2026, against a year earlier
4.17
0.02
−0.48%
Follow NUVB
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (49.09%) | (47.81%) | (39.51%) | (53.18%) |
+8 more TTM periods Free account |
|
| (19.70%) | (21.53%) | (26.48%) | (36.04%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(21.30%) | (23.40%) | (28.48%) | (41.77%) | |
Average Days of Receivables |
72.77 | 68.13 | 66.30 | 112.35 | |
Free Cash Flow per Share |
(0.31) | (0.35) | (0.36) | (0.51) | |
Free Cash Flow |
(108.17) | (120.92) | (126.06) | (173.78) | |
Capital Expenditures |
(1.98) | (0.40) | (0.33) | (0.35) | |
| Other line items | |||||
Cash ROIC |
(9.19%) | (10.39%) | (13.91%) | (19.57%) | |
Accounts Receivable Turnover |
7.46 | 8.85 | 9.10 | 3.53 | |
Accounts Payable Turnover |
2.31 | 1.16 | 0.80 | 1.18 | |
Inventory Turnover |
2.72 | 1.96 | 1.66 | 0.00 | |
Average Days of Payables |
120.26 | 219.64 | 620.60 | 372.11 | |
Days of Inventory on Hand |
195.26 | 361.57 | 438.28 | 447.95 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
65.77% | 75.84% | 87.77% | 182.99% | |
Selling, General and Administrative Expense of Revenue |
81.19% | 93.34% | 107.99% | 240.95% | |
Share Based Compensation of Revenue |
18.61% | 20.90% | 25.92% | 57.06% | |
Interest Coverage |
(4.70) | (5.16) | (7.38) | (15.57) | |
Operating CF/Net income |
0.78 | 0.80 | 0.86 | 0.85 | |
Depreciation/Fixed assets |
1.68 | 4.84 | 5.51 | 4.26 | |
Capex/Depreciation |
(0.53) | (0.12) | (0.11) | (0.15) | |
Revenue per Share |
0.57 | 0.49 | 0.41 | 0.18 | |
Operating CF per Share |
(0.30) | (0.35) | (0.36) | (0.51) | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.01 |
Columns are period end dates · fundamentals updated 6 Nov 2026